UK-based biopharmaceutical company F2G announced a $100 million financing round to advance late-stage development and commercialization of olorofim.
Eli Lilly says it will use OpenAI's generative AI to discover novel new antimicrobials.
Biotechnology company Elion Therapeutics announced it has closed an $81 million funding round to advance development of SF001, a novel polyene antifungal.
The infection is caused by Trichophyton mentagrophytes type VII, a fungus that may spread via sexual contact.
Retrospective reviews suggest the earliest confirmed US isolate was from 2017.
Even before COVID-19, diagnosis was challenging, but the pandemic made it even more so.
Incidence of blastomycosis in Vermont was found to be higher than reported in the states where it's considered endemic.
New estimates suggest 3.75 million deaths annually are linked to invasive fungal infections, of which 2.55 million are directly attributable.
A CDC-led study suggests the 6.5 million topical antifungal prescriptions filled for Medicare Part D beneficiaries in 2021 is a concern amid the emergence of antifungal-resistant skin infections.
Patient blood samples showed signs of persistent immune-system changes believed to be related to long COVID.
